INTRODUCTION {#S1}
============

Gap junction channels (GJCs) allow metabolic and electrical coupling between adjacent cells and are formed by the oligomerization of connexin (Cx) protein subunits. Cxs oligomerize to form hexamers called *hemichannels* (HCs), which reach the appositional plasma membrane and dock with other complementary HCs provided by an adjacent cell to form gap junction plaques ([@R42]). In non-appositional plasma membrane, HCs connect the cytoplasm with the external milieu, allowing paracrine and autocrine signaling mediated by ATP and Ca^2+^, among others ([@R38]; [@R43]). HCs can be homomeric, if all subunits are the same Cxs or heteromeric if they are formed by two or more different Cxs; however, some Cxs are incompatible to form heteromeric channels, like Cx26 and Cx43 ([@R14]; [@R20]; [@R32]). Indeed, heteromeric channels have different functional properties than homomeric channels; therefore, regulation of Cx-Cx interaction could be important in controlling intercellular communication ([@R20]; [@R31]; [@R32]).

Mutations in the human Cx26 gene accounts for about 50% of genetic deafness. To date, more than 100 Cx26 mutations have been identified, but only 16 of them, mainly located at the N-terminus and the transition between the first transmembrane segment and the extracellular loop segment, cause the syndromic phenotype ([@R30]). Although syndromic Cx26 mutations are sparse, they have an autosomal dominant inheritance pattern that affects proliferation and differentiation of skin keratinocytes, and produces progressive corneal neovascularization and hair and nail dystrophies like in Keratitis Ichthyosis Deafness (KID) syndrome ([@R2]; [@R7]; [@R21]). It is hypothesized that syndromic mutations produced gain of function HCs ([@R15]; [@R25]; [@R26]; [@R41]). However, some syndromic mutations, like Cx26S17F, lead to non-functional HCs, but they still developed a severe KID syndrome phenotype ([@R25]; [@R33]; [@R35]). Most of these studies have been performed in homomeric HCs, which may not reproduce what occurs in the disease. In human skin, Cx26 is co-expressed with Cx43, Cx30 and Cx31 ([@R40]); since KID syndrome is inherited as autosomal dominant condition, it is possible that KID mutations change the interaction and functional properties of Cx26 with other Cxs. Thus, to better understand the disease mechanisms, it is necessary to investigate the effect of Cx26 KID mutations when co-expressed with other Cxs found in the human skin.

Here, we functionally analyzed several N-terminus Cx26 mutants that were co-expressed, or not, with wild type Cx26 and Cx43. We focused on N14Y and S17F syndromic mutations, as well as two mutations located at residue 12 that can cause syndromic (G12R) or non-syndromic (G12V) deafness. The residue G12 is located inside the pore at the plasma membrane level ([@R22]; [@R29]), while residues N14 and S17 face the cytoplasm in the hinge region of the Cx26 N-terminus ([Figure 1, a1](#F1){ref-type="fig"}). The effect of two non-syndromic mutations, V37I and A40G, positioned at the TM1/ECL1 transition, was also assessed to compare interactions with wild type Cx26 and Cx43.

RESULTS {#S2}
=======

Non-syndromic and syndromic mutations located at the N-terminus segment of Cx26 reduce or eliminate GJC formation and/or function {#S3}
---------------------------------------------------------------------------------------------------------------------------------

To assess the effect of Cx26 mutations on the traffic, oligomerization and functional state of GJCs, HeLa cells were transfected with wild type Cx26 (Cx26 hereinafter) or deafness mutants attached to GFP to visualize their subcellular localization. All transfections were performed in a HeLa parental cell line that either does not express Cx26 and Cx43 ([Figure S1a](#SD1){ref-type="supplementary-material"}) or does not show GJCs currents ([Table S1](#SD1){ref-type="supplementary-material"}), confirming that this line is Cx-expression deficient. In contrast, we observed large GJ plaques in HeLa cells expressing Cx43, Cx26 ([Figure S1b](#SD1){ref-type="supplementary-material"}), Cx26-GFP or the non-syndromic Cx26G12V-GFP mutant ([Figure 1, a2,3](#F1){ref-type="fig"}) similar to that previously reported for non-syndromic mutants Cx26V37I and Cx26A40G ([@R20]). Conversely, syndromic mutants form few GJ plaques, suggesting intracellular trapping or preferential localization in non-appositional plasma membrane ([Figure 1, a4--6 and b](#F1){ref-type="fig"}).

We next evaluated the functional state of GJCs formed by homomeric mutations at the N-terminus. Dye-transfer and transjunctional conductance (g*~j~*), between cells expressing syndromic or non-syndromic mutants were indistinguishable from those obtained in untransfected cells ([Table S1](#SD1){ref-type="supplementary-material"}). Thus, these mutations completely abolished the formation of functional GJCs.

Syndromic N-terminus mutations affect Cx26 oligomerization {#S4}
----------------------------------------------------------

Diffuse cytoplasmic and/or perinuclear localizations ([Figure 1, a4--6](#F1){ref-type="fig"}) identified for syndromic mutants may reflect partial intracellular trapping due to defective protein oligomerization. This possibility was analyzed by velocity sedimentation assays in sucrose gradients. We found that the oligomeric and monomeric fractions of Cx26-GFP, Cx26G12V-GFP and Cx26G12R-GFP present similar sedimentation patterns to Cx26 ([Figure 1, c--f](#F1){ref-type="fig"}), which was consistent with those reported previously ([@R14]; [@R20]). However, for syndromic mutants Cx26N14Y-GFP and Cx26S17F-GFP ([Figure 1, g--h](#F1){ref-type="fig"}), their oligomeric fractions shifted to lower sucrose densities, suggesting the formation of intermediate arrangements with fewer hexamers.

To identify a potential dominant negative effect of Cx26 mutants on Cx26 GJC function, we co-expressed the GFP-tagged mutants with Cx26 containing a hemagglutinin tag (Cx26-HA). In these cells, all mutants co-localize with Cx26-HA and formed abundant and large GJ plaques between pair of co-expressing cells ([Figure S2, a--f](#SD1){ref-type="supplementary-material"}), suggesting that Cx26 rescues the traffic and delivery of syndromic mutants to appositional areas. Interestingly, all N-terminus mutants, either syndromic or non-syndromic, were not dominant negative of Cx26 GJCs. Nevertheless, we cannot rule out subtle changes in the channel permeability, since we found that GJCs formed by Cx26 and either syndromic mutant Cx26N14Y or Cx26S17F showed reduced coupling to Lucifer yellow (−2), but normal coupling to the smaller tracer neurobiotin (+1) ([Table S1](#SD1){ref-type="supplementary-material"}), suggesting that these channels are less permeable to negatively charged molecules and/or they have a reduce pore size.

Syndromic mutations in the N-terminus change the oligomerization compatibility of Cx26 {#S5}
--------------------------------------------------------------------------------------

Although Cx26 is co-expressed with Cx43 in cochlear cells ([@R13]) and skin keratinocytes ([@R2]; [@R6]; [@R34]; [@R35]; [@R40]) they are incompatible to form heteromeric channels ([@R14]). Hence we aim to study whether oligomerization of these incompatible Cxs result in compatible interactions as consequence of the syndromic mutations located at the N-terminus of Cx26. HeLa cells expressing Cx43 were transiently transfected with Cx26-GFP or mutants. We found that Cx43 and Cx26-GFP localize at the same plaques, but segregate in different regions ([Figure 2, a1--4](#F2){ref-type="fig"}), which is consistent with their oligomerization incompatibility ([@R14]). No co-localization was observed between Cx43 and the non-syndromic mutants Cx26G12V-GFP ([Figure 2a, 5--8](#F2){ref-type="fig"}), Cx26V37I-GFP or Cx26A40G-GFP ([Figure S3](#SD1){ref-type="supplementary-material"}). However, all syndromic mutants perfect co-localized with Cx43 in intracellular compartments and in GJ plaques ([Figure 2, a9--20](#F2){ref-type="fig"}), suggesting the formation of heteromeric channels. Consistently, Cx sedimentation analysis showed that only co-expression of Cx43 with any syndromic mutant ([Figure 2, e--g](#F2){ref-type="fig"}) promoted a shift in the sedimentation profiles of both proteins to overlap in a new oligomeric peak, which varied depending on the protein pair analyzed, confirming the formation of heteromeric channels between Cx43 and syndromic mutants. However, these heteromeric pairs produced non-functional GJCs, suggesting a total transdominant-negative effect of the syndromic mutants on Cx43 GJCs ([Table S1](#SD1){ref-type="supplementary-material"}). To rule out that the null GJC observed under previous conditions were not consequences of mutant Cx26 overexpression with respect to Cx43, we did transient transfection using different ratios of plasmid cDNAs carrying Cx43-RFP and Cx26-GFP or its mutant variants (1:1, 1:0.3 ratios, respectively) and then quantified the fluorescence for each fluorescent protein to demonstrate the relative reduction in the expression levels of each mutant Cx26 ([Figure S4](#SD1){ref-type="supplementary-material"}). Regardless of the ratio, we did not observed any junctional coupling in cell co-expressing Cx43-RFP with any Cx26 syndromic mutant ([Table S3](#SD1){ref-type="supplementary-material"}). Although we cannot estimate the molecular stoichiometry, our experiments suggest that the dominant negative effect of syndromic mutant over Cx43 GJC is strong. In addition, a previous report by Rouan and colleagues also showed that Cx26 with a syndromic mutation in TM1/EL1 is a negative dominant of Cx43 GJCs ([@R37]), suggesting that interaction with Cx43 would be a general feature of syndromic Cx26 mutants.

Syndromic mutations G12R and N14Y, but not S17F, produce homomeric HCs with gain of function {#S6}
--------------------------------------------------------------------------------------------

Because syndromic mutations are linked to gain in HCs function, we performed YO-PRO uptake assays to address HCs function. Under physiological extracellular Ca^2+^ concentration, HCs are mostly closed; however, cells that expressed the syndromic mutants Cx26G12R-GFP or Cx26N14Y-GFP showed uptake rates that were \~10 and \~4 times greater than what was observed in cells expressing Cx26-GFP, respectively, suggesting that both mutants increased the activity of homomeric HCs enhancing permeation to positively (+2) charged molecules ([Figure 3, b--c](#F3){ref-type="fig"}). This result is consistent with previous reports indicating that Cx26G12R mutation produces high HC activity in the presence of physiological extracellular Ca^2+^ concentrations ([@R25]). To further examine the presence of HCs in the cell membrane, dye-uptake was evaluated in divalent cation-free Hanks' balanced salt solution (DCF-HBSS), which enhances HC activity or in the presence of the lanthanum, a widely used HCs blocker. In this condition, YO-PRO uptake was significantly increased in cells that expressed Cx26 or all the mutants, except for Cx26S17F-GFP ([Figure 3, a--d](#F3){ref-type="fig"}). Conversely, YO-PRO uptake was partially or completely reduced in the presence of lanthanum in wild type and mutant HCs. The variation in YO-PRO uptake was not related to differences in expression levels ([Figure S1c](#SD1){ref-type="supplementary-material"}) neither depends on the expression levels of the mutants as revealed by the correlation analysis of the relative-uptake rate/GFP-expression ratio ([Figure S5a](#SD1){ref-type="supplementary-material"}).

A significant increase in YO-PRO uptake under normal extracellular Ca^2+^ concentration was recorded in cells that co-expressed Cx26 with Cx26G12R-GFP or Cx26S17F-GFP. Such increase was several times greater when compared to their respective homomeric counterparts or cells co-expressing Cx26 and Cx26GFP ([Figure 3, e--h](#F3){ref-type="fig"}). Nevertheless, HCs composed by Cx26 and Cx26G12V-GFP or syndromic Cx26N14Y-GFP are less active than their respective homomeric conformations and Cx26/Cx26-GFP HCs, which would reflect the formation of inactive HCs. Correlation analysis indicates that levels of uptake observed were not related to differences in expression levels ([Figure S5b](#SD1){ref-type="supplementary-material"}).

Syndromic mutants form hyperactive heteromeric HCs with Cx43 {#S7}
------------------------------------------------------------

We found no significant difference in YO-PRO uptake in cells co-expressing Cx43 with Cx26-GFP or with non-syndromic mutants Cx26G12V-GFP ([Figure 3, j--k](#F3){ref-type="fig"}), Cx26V37I-GFP or Cx26A40G-GFP ([Figure S3](#SD1){ref-type="supplementary-material"}). In contrast, uptake mediated by heteromeric HC formed by all syndromic mutants with Cx43 showed higher uptake, even in the presence of divalent cations ([Figure 3, j--k](#F3){ref-type="fig"}), which was boosted after the removal of extracellular Ca^2+^ ([Figure 3, l](#F3){ref-type="fig"}), suggesting that these heteromeric HCs are still sensitive to Ca^2+^. The effects described here were not a consequence of different expression levels of Cx26 mutants, because they were observed even in cells that express low levels of syndromic mutant Cxs ([Figure S4, S5c](#SD1){ref-type="supplementary-material"}).

To unequivocally assess those Cx26 mutations that increase HCs activity when forming homomeric and heteromeric HCs, we performed electrophysiological studies using the two-electrode voltage clamp technique. Macroscopic currents were elicited by depolarizing pulses in *Xenopus laevis* oocytes expressing homomeric and heteromeric HCs, to examine the current-voltage relationship. Consistent with previous reports ([@R18]; [@R47]), oocytes expressing human Cx43 did not exhibit detectable HCs macroscopic currents ([Figure 4, a](#F4){ref-type="fig"}). The lack of HCs currents was also observed in oocytes expressing Cx26G12V, Cx26N14Y or Cx26S17F alone ([Figure S6](#SD1){ref-type="supplementary-material"}). To evaluate heteromeric HCs currents, equal amounts of cRNA were co-injected in oocytes to obtain 1:1 protein expression ratios. Co-expression of Cx43 with the non-syndromic G12V mutant did not elicited HCs currents ([Figure 4; c,g](#F4){ref-type="fig"}), supporting our findings than these proteins do not interact. Conversely, co-expression of Cx43 with the syndromic Cx26G12R and Cx26S17F mutants promotes larger HCs currents ([Figure 4; d,f](#F4){ref-type="fig"}). Lower HCs currents were detected in oocytes co-expressing Cx43 and the Cx26N14Y mutant ([Figure 4, e](#F4){ref-type="fig"}), yet they were significantly larger at high positive potentials (\>50 mV) than those observed for oocytes expressing Cx43 or Cx26N14Y alone. Co-expression of Cx26 and Cx43 showed HCs currents with similar kinetic to those previously described for Cx26 alone ([@R27]; [@R28]).

Expression of heteromeric channels formed by Cx26 syndromic mutants and Cx43 promotes intracellular Ca^2+^ overload and ATP release {#S8}
-----------------------------------------------------------------------------------------------------------------------------------

Compelling evidence has indicated the existence of a strong relationship between HC activity and increments in intracellular Ca^2+^ concentration and ATP release ([@R12]; [@R39]; [@R44]), both are important for normal functioning of the cochlea and skin ([@R1]; [@R11]). To determinate changes in basal cytosolic Ca^2+^ levels from HeLa cells expressing homomeric and heteromeric HCs, cells loaded with the non-ratiometric probe Fura-Red were incubated in normal extracellular solution. Only cells that co-expressed Cx43 with syndromic mutants showed higher intracellular Ca^2+^ signal, which was almost saturated as indicated by treating these cells with 10 μM ionomycin that only produced a minor increase in the Ca^2+^ signal ([Figure 5; a,b](#F5){ref-type="fig"}). Because Fura-Red has very limited sensitivity to Ca^2+^ concentration (above 1 μM), we also used Indo-1AM to more accurately estimate changes in the intracellular Ca^2+^ concentration among different mutants. HeLa cells expressing homomeric HCs, formed by Cx26G12R or Cx26N14Y mutants, but not Cx26S17F, exhibit higher levels of the intracellular Ca^2+^ when compared to HeLa cells expressing homomeric wild type Cx26 ([Figure S7](#SD1){ref-type="supplementary-material"}). Consistently with the Ca^2+^ overload reported by the Fura-Red experiments, cells co-expressing Cx43 with any syndromic mutants showed elevated intracellular Ca^2+^ concentration. In particular, cell co-expressing Cx43 and Cx26S17F display intracellular Ca^2+^ levels almost two folds than those measured in cell co-expressing the wild type counterparts ([Figure 5, c](#F5){ref-type="fig"}).

Because extracellular ATP release correlates with HC activity ([@R44]), we explore HCs basal ATP release. As expected for hyperactive HCs, we found that ATP release augmented in cells expressing heteromeric HCs formed by Cx43 with any syndromic Cx26 mutants ([Figure 5, d](#F5){ref-type="fig"}).

DISCUSSION {#S9}
==========

In the present work, we propose a possible molecular mechanism that might underlie the severity of KID syndrome by mutations at the N-terminus segment of Cx26. We demonstrate that Cx26 syndromic mutations produce aberrant Cx-Cx interactions leading to the formation of heteromeric HCs and GJCs with Cx43. These heteromeric HCs, but not GJCs, present exacerbate activity (gain in function) that may lead to dysfunction of paracrine signaling and Ca^2+^ overload ([Figure 5, c](#F5){ref-type="fig"}; [Table S4](#SD1){ref-type="supplementary-material"}). Although KID syndromic mutations have been previously associate to hyperactive HCs, some syndromic mutations formed inactive homomeric HCs contradicting the previous mechanistic explanation for the disease. Because both, Cx26 and Cx43, are highly expressed in the human skin ([@R40]), we propose that all syndromic mutations at the N-terminus could produce the functional paradox of hyperactive heteromeric HCs (Cx43/Cx26 mutants), but non-functional GJCs, which can enhanced severe skin damage in patients carrying these mutations ([@R33]).

At the molecular level, our data demonstrate a critical role of the N-terminus in controlling Cx oligomerization. We found that mutations facing the cytoplasmic environment (i.e., Cx26N14Y and Cx26S17F) disrupt the proper formation of hexamers, but still allow the formation of intermediate Cx oligomers ([Figure 1; g,h](#F1){ref-type="fig"}). The latter is consistent with the formation of Cx26 dimers that depend on TM1 ([@R20]) as the first step into the oligomerization process. However, mutations in the N-terminus might affect subsequent steps in hexamer formation, like the check point for oligomerization compatibility between Cxs. Our results support the idea that such check point is located in the Cx26 N-terminus, as it has been previously suggested for this Cx ([@R20]; [@R24]; [@R30]) and for acetylcholine receptors ([@R45]). These results are consistent with the notion that an intact N-terminus is critical for the formation ([@R23]) and proper functioning of GJCs, since this segment is part of the transjunctional voltage sensor ([@R46]) and gating mechanism ([@R3]; [@R4]; [@R29]).

Consistent with previous studies ([@R25]) and with the YO-PRO uptake experiments, we observed that *Xenopus* oocytes expressing homomeric Cx26S17F mutants do not display HCs currents upon membrane depolarization. Suggesting that this mutation drastically decrease open probability and/or ionic conductance in homomeric HCs. Similarly, Cx43 when expressed in *Xenopus* oocytes does not show macroscopic HCs currents, but it does allow uptake of ethidium bromide ([@R18]). Only few single Cx43 HCs with very low open probability have been detected in the whole-cell configuration from cells expressing high levels of Cx43 proteins at the plasma membrane ([@R8]), yet significant dye uptake is observed over larger periods of time-video recording ([@R38]; [@R39]). Remarkably, we showed that the co-expression of Cx43 and Cx26S17F results in large HCs currents ([Figure 4, f](#F4){ref-type="fig"}), which can only be explained by formation of heteromeric HCs between these two Cxs, as supported by co-localization and velocity sedimentation assays. Similar results were found when Cx26N14Y and Cx26G12R were co-expressed with Cx43. Conversely, the non-syndromic mutant Cx26G12V did not show significant levels of HCs currents or dye uptake when co-expressed with Cx43, consistently with the biochemical data showing that this mutation does not lead to the formation of heteromeric HCs with Cx43, but it does interacts with wild type Cx26, without the formation of hyperactive functional HCs. Similar results were observed for non-syndromic mutants Cx26V37I and Cx26A40G.

In KID syndrome several tissues are affected but the most extensive damage is observed at the epidermis, a tissue were Cx26 and Cx43 are the main Cxs expressed ([@R16]; [@R40]; [@R48]) playing a critical role in keratinocytes homeostasis maintenance and migration from the basal to cornified layer ([@R36]). Overexpression and ectopic expression of Cx26 are associated with psoriatic plaques and ATP release, delayed epidermal barrier recovery and inflammatory responses ([@R11]). In addition, a KID patient carrying mutation N14Y present also ectopic skin expression of Cx26 that co-localized with Cx43 ([@R2]). Additionally, P2X purinergic receptors are expressed in the skin and ATP signaling is important for differentiation and proliferative processes in keratinocytes as well as hyperplasia induced after skin barrier disruption ([@R10]). Our findings show that the expression of syndromic heteromeric HCs and GJC increases basal concentrations of intracellular Ca^2+^ and ATP release, are consistent with the notion that both signaling agents permeate through HCs ([@R12]; [@R44]). Our results support the notion that KID syndrome involves keratinocyte homeostasis misregulation as consequences of leaky heteromeric HCs but non-functional GJC, which might promote ATP release, intracellular Ca^2+^ overload and cell death and/or proliferation ([Figure 5, e](#F5){ref-type="fig"}). Hence this study supports the idea to use HC blockers as possible therapeutic agents for this disease.

MATERIALS AND METHODS {#S10}
=====================

Molecular cloning {#S11}
-----------------

Wild type rat Cx26 cDNA (accession: NM_001004099) was cloned in the pcDNA3.1/CT-GFP-TOPO vector (Invitrogen). Site-directed mutagenesis was generated using the Quick-Change II kit (Agilent Technologies). For some experiments Cx26 or its variants contain hemagglutinin epitope tag appended to their C-terminus. Primers sequences are detailed in [supplementary Table S2](#SD1){ref-type="supplementary-material"}. DNA was sequenced by Macrogen Inc (Seoul, Korea), and analyzed using the "Vector NTI Advance" software (Invitrogen).

Immunofluorescence {#S12}
------------------

Parental HeLa cells transfection and immunofluorescence were performed as previously described ([@R20]). Antibodies against Cx43, Cx26, and anti-HA (hemagglutinin) were from Invitrogen (Invitrogen). Images acquisition was performed with a Nikon Eclipse C1-Plus confocal microscope, Image processing and 3D reconstruction, were using the EZ-C1 and the NIS-Elements Viewer 4.0 software, respectively (Nikon Instruments Inc).

Velocity of sedimentation in sucrose gradients and immunoblotting {#S13}
-----------------------------------------------------------------

Transfected HeLa cells were harvested and lysed as indicated previously ([@R20]). Soluble fractions were subjected to sedimentation velocity through 5--20% (w/v) linear sucrose gradients, as previously described ([@R5]; [@R20]). To determine the percentage of sucrose at which Cx monomers sediment, Triton X-100 soluble fractions were treated with SDS to disaggregate the oligomers. After centrifugation for 22 h at 100,000g, 250 μL-fractions were collected and analyzed by immunoblotting as previously described ([@R20]; [@R31]).

Measurement of GJC activity {#S14}
---------------------------

Intercellular dye-coupling was performed as previously described ([@R20]; [@R31]), and visualized with a Nikon TE-2000U inverted microscope (Nikon ACT-2U, Tokyo, Japan). The results are reported as incidence of coupling, that is, the percentage of microinjections that resulted in tracer diffusion to one or more adjacent cells. Electrophysiological recordings in pairs of HeLa cells were done with double whole-cell patch clamp essentially as described in ([@R20]). Total gap junctional conductance (g~j~) was calculated by using the formula (g~j~=I~j~/\[V~j\ cell\ 1~ -- V~j\ cell\ 2~\]).

Assessment of hemichannel activity {#S15}
----------------------------------

Cells plated on glass coverslips were bathed in physiological extracellular solution containing 200 nM of YO-PRO-1 uptake (375 Dalton/+2) and subjected to dye uptake time-lapse imaging as described previously ([@R9]; [@R20]). The bath solution was replaced by Ca^2+^-Mg^2+^-free solution (DCF-HBSS, Invitrogen) containing 200 nM YO-PRO-1, and tracer uptake was recorded for 20 min, followed by the addition of 100 μM LaCl~3~ (Sigma-Aldrich) for an additional 10 min. Regions of interest were obtained with a 40X objective in a NIKON TE-2000U inverted microscope, and captured with a Nikon DS-2WBc fast-cooled monochromatic digital camera (8-bit) every 60 s. Image analysis and quantification of fluorescence intensity were performed with Image J (<http://rsbweb.nih.gov/ij/>).

Molecular cloning and HCs electrophysiology {#S16}
-------------------------------------------

Wild-type human Cx26 (hCx26) cDNA was purchased from OriGene and was subcloned in the pGEM-HA vector (Promega) for *in vitro* translation. Mutations of hCx26 were produced with Quick-Change II Site-Directed Mutagenesis kits (Agilent Technologies). DNA sequencing performed at the New Jersey Medical School Molecular Resource Facility confirmed the amino acid substitutions. Nhe1-linearized hCx26 wild type, Cx43 and mutant DNAs were transcribed in vitro to cRNAs using the T7 Ultra mMessage Machine kit (Ambion). Electrophysiological data were collected using the two-electrode voltage-clamp technique as in our previous studies ([@R27]).

Ca^2+^ imaging {#S17}
--------------

Ionomycin-induced Ca^2+^ overload was measured by imaging of Fura-red acetoxymethylester (Invitrogen). Briefly, HeLa cells growing in coverslips were loaded with 15 μM Fura-red for 20 min at room temperature. Each coverslip was placed in a perfusion chamber mounted on an IX81 inverted epifluorescence microscope (Olympus) equipped with a 40x/1.4 NA oil-immersion objective. Images analysis was performed using the Excellent Pro software. The relative fluorescence ratio was calculated by dividing fluorescence (F) at each time point by the initial fluorescence value (F~0~).

Intracellular Ca^2+^ concentration was measured using Indo-1AM (Molecular Probes, Invitrogen) based on the standard ratio method ([@R17]; [@R19]). Briefly, HeLa cells growing in 25 mm coverslips were loaded with 5 μM Indo-1AM (dissolved in 20% pluronic acid in DMSO) for 30 min at 37°C in normal extracellular solution. Each coverslip was placed in a perfusion chamber mounted on the stage of a microscope (Diaphot 200-Nikon, Japan) equipped with a photomultiplier (Micron System, MS878). Indo-1 signals were amplified with an EPC 10-USB amplifier (HeKa Electronics). Analogue/digital signal conversion was performed with a DigiData 1200 Series card (Axon Instruments, Inc). The Patch Master program (HeKa Electronics) was used for data acquisition, and data analysis was carried out with the Igor6 software.

Extracellular ATP measurements {#S18}
------------------------------

ATP release was assessed with the luciferin/luciferase based ATP Determination Kit (Molecular Probes, Invitrogen). Briefly, for each condition, 50,000 cells/well were seeded in a 24-well plaque. Twenty-four hours later, the culture medium was washed out and replaced with HBSS containing 1.8 mM Ca^2+^, and cells were incubated for 10 min at 37°C. Subsequently, 5 μL samples of extracellular milieu were mixed with 45 μL ATP-mix solution in a 96-well plaque. Accumulated ATP was determined using an Appliskan Luminometer (Thermo Electro Corporation) based on a calibration curve range from 1 nM to 1 μM ATP. Data was collected with the SkanIT software (Thermo Electro Corporation).
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![Syndromic mutations reduce or eliminate GJC formation\
***(a1)*** TM1 and NT of two Cx26 subunits with highlighted residues at the NT that are linked to deafness mutations. Yellowish rectangle indicates plasma membrane region. ***(a2--6)*** Confocal images show the respective subcellular localization of cells expressing Cx26 wild type or mutants. White arrows indicate GJ plaques. ***(a2 and 6)*** Arrowheads indicate perinuclear labeling. Bar=15 μm. ***(b)*** Percentage of paired cells expressing GJ plaques per condition. (\*\*\**p*\<*0.001*; n=5, 250 paired cells for condition). ***(c--h) Syndromic mutations, N14Y and S17F, affect oligomerization***. Graphs represent the sedimentation profile of monomer and oligomers (in arbitrary units of Cx amount, a.u.) of WT or mutants Cx26. SDS treated fractions (red triangles). Black-filled arrows in (c) show the hexameric peak, and the unfilled arrows show monomeric peaks. Light blue columns indicate where WT Cx26 hexamers sedimented (n=4).](nihms657326f1){#F1}

![Syndromic mutations change the oligomerization compatibility of Cx26\
***(a)*** Confocal images of HeLa cells co-expressing Cx43 (red labeling) with WT or mutants Cx26. Arrows point GJ plaques. Arrowheads show perinuclear staining. Nuclei were staining with DAPI. Dashed rectangles in the merged panels show regions of interest for 3D image projections. Bar=10 μm. ***(b,c)*** Cx43 and Cx26-GFP do not co-sediment in the same oligomeric fractions. Graphs represent the levels of Cx43 and Cx26GFP in each sucrose fractions in samples from HeLa cells that were transfected with Cx43 **(*b*)** or co-transfected with Cx43 and Cx26-GFP ***(c)***. Samples treated with SDS (red square). ***(d--g)*** Syndromic mutants co-sediment with Cx43 in new oligomeric fractions. Graphs show levels of Cx43 and mutant Cx26 in sucrose gradient fractions from cells co-transfected with Cx43 and the respective mutant. (n=4).](nihms657326f2){#F2}

![All syndromic mutants form hyperactive heteromeric HCs with Cx43\
The functional state of HCs was determined in time-lapse experiments of YO-PRO uptake by HeLa cells expressing Cx26-GFP (open symbols), Cx26G12V-GFP (light blue), Cx26G12R-GFP (red), Cx26N14Y-GFP (yellow) or Cx26S17F-GFP (blue) ***(a--d)*** or by cells co-expressing these constructs with WT Cx26 ***(e--h)*** or Cx43 ***(i--l)***. a, e, i) Uptake under physiological extracellular divalent cation concentrations (w/DC) for 10 min, followed by a 20 min bath in Ca^2+^/Mg^2+^ free (DCF-HBSS). Then, 100 μM La^3+^ was added to block HCs. (b, f, j) Magnification of the area indicated by the rectangle in the graph (a,e,i). (c,d; g,h; k,l) The rate of uptake was determined calculating the uptake slope in cells bathed with physiological (c, g, k) or DCF-HBSS (d, h, l) solution. Data is presented as average ± SEM (n= 7). t-Test for unpaired data. \*\*\* *p*\<*0.001*; \*\**p*\<*0.01*; \**p*\<*0.05*](nihms657326f3){#F3}

![Heteromeric HCs composed by Cx43 and the syndromic mutants produce large macroscopic currents\
Membrane currents from oocytes expressing Cx43 alone or Cx43 with Cx26 mutants were recorded using the two-electrode voltage clamp technique. HC currents were activated in response to depolarizing voltage steps from a holding potential of −10 mV, and stepped in 20 mV increments from −100 mV to + 60 mV. Representative currents traces are showed for hCx43 alone ***(a)*** or for hCx43 coexpressed with wild type Cx26 ***(b)***, hCx26G12V ***(c)***, hCx26G12R ***(d)***, hCx26N14Y ***(e)*** or Cx26S17F ***(f)***. ***(g)*** Graphic depicted the current voltage relationship of macroscopic heteromeric HCs. The data represent mean ± SEM of at least five independent experiments.](nihms657326f4){#F4}

![Heteromeric hemichannels formed by syndromic mutants and Cx43 promote cellular Ca^2+^ overload and ATP release\
***(a)*** Time course of Ca^2+^ signal obtained with probe Fura-Red in cells expressing Cx43 (gray), or co-expressing Cx43 with non-syndromic Cx26G12V-GFP (green), or syndromic Cx26G12R-GFP (red) and Cx26S17F-GFP (blue) before and after application of the Ca^2+^ ionophore ionomycin (100 μM). ***(b)*** Percentage of the Ca^2+^ signal increments induced by ionomycin. ***(c)*** Intracellular Ca^2+^ concentration in HeLa cells or in cells expressing Cx43, or co-expressing Cx43 with Cx26-GFP or Cx26S17F-GFP. ***(d)*** Measurement of ATP release during 10 min of cellular incubation of HeLa cells co-expressing Cx43 with the N-terminus mutants. Data is presented as average ± SEM (n= 20). t-Test for unpaired data. \*\*\* *p*\<*0.001*; \*\**p*\<*0.01*; \**p*\<*0.05* ***(e)*** Model of cell signaling induced by expression of aberrant heteromeric HCs but nonfunctional GJCs in KID syndrome.](nihms657326f5){#F5}
